U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Grants > Search Current & Recent Grants > Reducing Intersectional and HIV Stigma among High Risk Women who use Drugs in Kazakhstan, Central Asia: A Multilevel Stigma Resistance and Enacted Stigma Reduction Intervention for Women and Providers Print

Reducing Intersectional and HIV Stigma among High Risk Women who use Drugs in Kazakhstan, Central Asia: A Multilevel Stigma Resistance and Enacted Stigma Reduction Intervention for Women and Providers

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

Stigma HIV/AIDS

Project Information in NIH RePORTER

Reducing Intersectional and HIV Stigma among High Risk Women who use Drugs in Kazakhstan, Central Asia: A Multilevel Stigma Resistance and Enacted Stigma Reduction Intervention for Women and Providers

Principal Institution

Columbia University New York Morningside

Principal Investigator(s) (PI)

West, Brooke S.; Frye, Victoria

Project Contact Information

Email: bsw2110@columbia.edu

Year(s) Awarded

2022–2025

Country

Kazakhstan

NIH Partners

NIDA

Project Description

Suboptimal linkage to and retention in HIV prevention and care is prevalent among high risk women who use or inject drugs in both the U.S. and globally, including high HIV incidence contexts like Kazakhstan. addressing HIV and intersectional stigma, especially from health care providers (HCP) within clinics, is necessary to increase engagement in the HIV care and prevention continuum. 

To address this challenge and increase HIV prevention and care, the study will involve the design and assessment of the acceptability, feasibility, and usability of a three-component, multi-level participatory intervention to promote stigma resistance/coping and reduce anticipated/internalized stigma among high risk women who use drugs as well as to reduce enacted stigma among HCP in Kazakhstan.

Related World Regions / Countries

Related Global Health Research Topics